C3 and early-onset autosomal dominant Alzheimer disease: Since overactivation of the complement system and C3‐mediated brain injury are common in animals and humans, our findings could lead to the use of a potentially universal strategy for treating several neurological disorders, including Alzheimer's disease (AD), TBI, epilepsy and depression.41, 42, 43, 44